1. Home
  2. VREX vs ZVRA Comparison

VREX vs ZVRA Comparison

Compare VREX & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Varex Imaging Corporation

VREX

Varex Imaging Corporation

SELL

Current Price

$18.41

Market Cap

783.5M

Sector

Technology

ML Signal

SELL

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$9.81

Market Cap

689.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VREX
ZVRA
Founded
2016
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
783.5M
689.4M
IPO Year
2016
2015

Fundamental Metrics

Financial Performance
Metric
VREX
ZVRA
Price
$18.41
$9.81
Analyst Decision
Hold
Strong Buy
Analyst Count
3
9
Target Price
$18.90
★ $25.00
AVG Volume (30 Days)
457.5K
★ 744.9K
Earning Date
11-17-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 159.21
EPS
0.23
★ 0.74
Revenue
★ $811,000,000.00
$106,470,000.00
Revenue This Year
$2.52
$43.97
Revenue Next Year
$3.97
$15.93
P/E Ratio
$80.07
★ $14.00
Revenue Growth
N/A
★ 350.91
52 Week Low
$9.09
$8.01
52 Week High
$18.63
$15.04

Technical Indicators

Market Signals
Indicator
VREX
ZVRA
Relative Strength Index (RSI) 59.72 36.35
Support Level $18.35 $9.29
Resistance Level $18.63 $11.19
Average True Range (ATR) 0.05 0.46
MACD -0.06 -0.03
Stochastic Oscillator 36.67 3.61

Price Performance

Historical Comparison
VREX
ZVRA

About VREX Varex Imaging Corporation

Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Share on Social Networks: